TiGenix in advanced talks over Dutch facility, drug partnering

Belgian biotech company TiGenix said on Tuesday it was in advanced discussions to sell its Dutch manufacturing facility and separately to find a partner for its candidate treatment for a disorder linked to Crohn's disease. TiGenix said the renewal by Dutch authorities of its license for the plant in Sittard-Geleen had allowed it to move ahead with talks on selling the facility while continuing to make its drugs there. TiGenix is enrolling patients for Phase III trials for Cx601 for the treatment of complex perianal fistulas, abnormal channels that can develop between the end of the bowel and the skin, in patients of bowel disorder Crohn's disease.



via Health News Headlines - Yahoo! News http://news.yahoo.com/tigenix-advanced-talks-over-dutch-facility-drug-partnering-070715188--finance.html